AstraZeneca buying drug developer Alexion for $39 billion
Pharmaceutical company AstraZeneca says it's buying U.S. drug developer Alexion in a deal worth $39 billion
Pharmaceutical company AstraZeneca says it's buying U.S. drug developer Alexion in a deal worth $39 billion